lobbying_activities: 1116136

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1116136	6e98dad6-4517-4475-a6c8-cb5b184336b6	Q2	EISAI INC.	400321512	EISAI INC.	2011	second_quarter	PHA	Drug issues, generally. Prescription Drug User Fee Act reauthorization. FDA-DEA issues biosimilars implementation	HOUSE OF REPRESENTATIVES,SENATE		670000	0	0	2011-07-18T09:31:38.217000-04:00